I think you're right. And, we'll see. Maybe he cancels some altogether. Or converts common to non-convertible redeemable preferred stock. If so, what if any dividend or RoR on these Preferreds? Maybe just Preferred shares with asset rights. That would really pull them out of circulation to boost market capitalization and EPS without ongoing dilutive payments.
Marshall also previously mentioned getting Medical Care Technologies annually audited.
These two completed company actions would be very significant.
News 
Market Data 
Discover 
AI
